Piramal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2026 ,inter alia, to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for quarter and nine months ended 31st December, 2025.